SuperworthAura Biosciences market cap AURA
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $653.3M
- Highest close in our data
- $826.1M
- Aug 2026
Aura Biosciences is worth $653.3M at the close on Oct 23, 2026, at $6.30 a share.
That is up 79% over the last year and down 1% over five years.
Its highest close in our data was $826.1M in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $653.3M | $318.8M | $826.1M | +75% |
| 2025 | $372.8M | $262.7M | $422.1M | −10% |
| 2024 | $416.1M | $275.5M | $582.4M | +23% |
| 2023 | $339M | $276.9M | $479.7M | +10% |
| 2022 | $308M | $308M | $642.6M | −38% |
| 2021 | $496M | $468.5M | $660.7M | n/a |
Against its peers
Companies in Biotechnology nearest Aura Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| AURAAura Biosciences | $653.3M |
| MGTXMeiraGTx | $884.6M |
| PLXProtalix BioTherapeutics | $205.5M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Aura Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.